Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
woundsHealthylife provides only prescription products, which Healthylife does not sell or recommend not changes. Healthylife does not promote theitude of harm or the sale of any category of drugs or medical devices. Healthylife does not sell, or recommend that you disclose any allergies to any drugs you are taking. |
Healthylife does not promote theaftis of any drugs you are taking. Healthylife does not promote theiology of any drugs you are taking.
Atomoxetine is a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD), which affects both adults and children alike. It is a selective serotonin reuptake inhibitor (SSRI) that helps the brain re-establish communication between neurons in the brain.
Atomoxetine is used to treat Attention Deficit Hyperactivity Disorder (ADHD) in adults and children. It works by increasing the levels of certain chemicals in the brain that are necessary for attention, motivation, and behavior. Strattera is a prescription medication that helps treat ADHD by boosting the levels of dopamine and norepinephrine in the brain.
Atomoxetine is a selective serotonin reuptake inhibitor (SSRI) that works by increasing the levels of certain chemicals in the brain. The effects of atomoxetine can be as simple as increasing the amount of dopamine in the brain, which helps improve focus and concentration.
Like many medications, atomoxetine can cause side effects in some individuals. Common side effects include drowsiness, dizziness, weakness, nausea, and headaches. If you experience any of these symptoms, contact a healthcare professional immediately.
It is important to note that atomoxetine is not approved for use by the FDA for the treatment of ADHD. It is only approved to treat ADHD and is not recommended for children and adolescents (up to 17 years of age).
Atomoxetine is only approved for use by adults and children, and may not be suitable for individuals who have certain medical conditions or who have a history of bleeding disorders or seizures. Anyone who is considering using Atomoxetine for an increased risk of bleeding should inform their healthcare provider.
Individuals who are allergic to Atomoxetine or who have a history of seizures or other psychiatric conditions should avoid using atomoxetine. Individuals who have a history of bleeding disorders should also avoid using atomoxetine.
As with any medication, atomoxetine can interact with other medications, potentially leading to unintended consequences. It is important to inform any individuals using atomoxetine about potential drug interactions to avoid potential adverse reactions.
Atomoxetine is available as 60mg and atomoxetine as 60mg. The dosage is based on the condition being treated and any individual's response to the medication.
It is important to follow the prescribed dosage and duration to ensure optimal effectiveness and safety. Dosage adjustments may be required based on individual needs and response to the medication.
Individuals who are pregnant or breastfeeding should also avoid using atomoxetine, as the medication can cause fetal abnormalities and may harm the unborn child.
Inform a healthcare professional if using atomoxetine to treat ADHD.
Individuals who have a history of depression, bipolar disorder, or other neurological disorders should also inform their healthcare provider about any other medications they are taking, as atomoxetine can affect the way other medications are metabolized.
It is crucial to understand the potential interactions between atomoxetine and other medications to ensure that they are taken safely and effectively.
Atomoxetine is only approved to treat ADHD and should be used with caution by individuals who are currently using stimulants, sleeping pills, or other medications that increase levels of dopamine in the brain.
Individuals who are considering using atomoxetine should discuss alternative treatment options with their healthcare provider before starting treatment. It is important to inform any individuals using atomoxetine about potential risks and side effects with the potential for adverse reactions to ensure the safety of their treatment.
Strattera is a medication that is commonly used to treat ADHD. It belongs to a class of drugs called non-stimulants, which work by increasing the levels of certain chemicals in the brain. It is important to note that atomoxetine is not approved for the treatment of ADHD.
Atomoxetine is not approved for the treatment of ADHD.
Strattera Vs. Other Stimulants: An Overview of the Therapeutic Option
A Brief Overview of the Therapeutic Option
Strattera, also known by its generic name atomoxetine, is an important medication in the treatment of attention-deficit/hyperactivity disorder (ADHD). This drug is an antianxiety agent that works by enhancing the natural balance of neurotransmitters in the brain, helping to improve attention and reduce the severity of symptoms associated with ADHD. Strattera is often prescribed for ADHD but is often prescribed in combination with other medications to improve attention and reduce the symptoms of the disorder.
Strattera, also known by its generic name atomoxetine, belongs to a class of medications called selective norepinephrine reuptake inhibitors. These drugs act on the central nervous system to increase the activity of certain chemicals in the brain. When a neurotransmitter in the brain is reuptaken, it helps to increase the availability of norepinephrine, which can help regulate attention and reduce symptoms of ADHD.
Strattera is not just a medication for ADHD but also for conditions like obsessive-compulsive disorder (OCD), attention-deficit hyperactivity disorder (ADHD) and hyperactive-impulsive disorder (HDD). By increasing the availability of norepinephrine in the brain, Strattera helps to treat the symptoms of these conditions.
This medication is most effective when taken as a daily pill, and is not recommended for long-term treatment. Strattera may cause more side effects when used at high doses, leading to increased side effects such as weight gain, drowsiness, and difficulty sleeping.
Strattera can interact with other medications and substances, and is not recommended for long-term use. It is important to discuss with your healthcare provider if you are taking or are taking any medications, especially those that are known to increase the risk of side effects. If you are taking a medication that increases the risk of side effects, discuss the risks and benefits with your healthcare provider.
This section reviews the safety and effectiveness of various medications and supplements in the treatment of ADHD. Read the full product information provided by our manufacturer for further information.
The Therapeutic Option
Strattera, also known as atomoxetine, is a medication that has a unique mechanism of action.
Atomoxetine HCL, commonly known by its brand name Strattera, is a non-stimulant medication prescribed to treat Attention-Deficit Hyperactivity Disorder (ADHD). It works by increasing the levels of norepinephrine in the brain, which helps improve attention, focus, and impulse control[2].
The global Atomoxetine HCL API market is experiencing significant growth, driven by several key factors:
North America is expected to hold the largest share of the global Atomoxetine HCL API market, accounting for the majority of the growth. The high prevalence of ADHD and cardiovascular diseases is a prominent ethnicity trend in the market. This region is anticipated to be the fastest to experience the in terms of growth[1].
Europe also has a significant demand, with the expected market cap of $8.6 billion in 2023. The region's high prevalence of ADHD and cardiovascular conditions is a significant driver due to its educational objectives and quality of life[1].
The Asia Pacific region is expected to witness the fastest rate of growth, driven by increasing technologicalcrunch and rising preferences for healthcare infrastructure. This region is predicted to be the fastest to experience in terms of CAGR in 2033. The region's rate of adoption is expected to be highest in the developed region, with B2G access expected to be limited by the rising prevalence of ADHD[1].
Latin America and the Middle East & Africa are expected to hold the fastest rate of growth, driven by rising educational expectations and increasing awareness about infectious diseases. This region is expected to be the fastest to experience in terms of CAGR[1].
The global ADHD diagnosis rate has increased significantly from about 1 in 100 in 2002 to approximately 6 in 10, with the rate increasing with more diagnosed cases� making Atomoxetine HCL a strong driver. The rising prevalence of ADHD is a significant driver, as it is often linked to distractions and behavioral challenges. ADHD is often diagnosed early, as it is not related to brain chemistry but instead is initiated by an "arousal process" where neurotransmitters like dopamine and serotonin transmit messages between the brain's neurons[2][3].
The cardiovascular condition Atomoxetine HCL is commonly diagnosed due to its vasodilatory properties, which increases blood flow. This can help improve blood pressure and lower blood pressure, making ADHD a strong driver. However, the Asia Pacific region is expected to witness the fastest growth, driven by increasing numbers of diagnosis and increasing ADHD access. The region's rate of adoption is expected to be highest in the leading nations, followed by others. The rapid expansion of healthcare infrastructure and increasing awareness about ADHD are strong drivers for market growth[1].
The global Atomoxetine HCL API API prices are significantly lower, depending on how much of a substance Strattera contains and which region it is in. The average cost of a one tablet Atomoxetine HCL box of $...................................................................................................................................................... strous.................................................. Angola & Barbados.................. United Kingdom...................Lower cost generic: The cost for a 90-day supply of 80 tablets of Atomoxetine HCL is $.................................................... strous....................................................
The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
Strattera-10-MG-Oral-Capsule
Atomoxetine is used to treat attention-deficit hyperactivity disorder (ADHD) as part of a total treatment plan, including psychological, social, and other treatments. It may help to increase the ability to pay attention, concentrate, stay focused, and stop fidgeting. It is thought to work by restoring the balance of certain natural substances (neurotransmitters) in the brain.
Stomach upset, nausea, vomiting, constipation, tiredness, loss of appetite, dry mouth, dizziness, drowsiness, trouble sleeping, or decrease in sexual ability or ability to have an erection will be serious side effects. If any of these symptoms persist for more than 10 days, please speak with your doctor. This medication does not need to be given every day. If you are taking it for an enlarged prostate, or if you have a heavy meal, give it 30 minutes to act on the enlarged prostate, or stop taking this drug, tell your doctor right away. This drug may affect the way.............
Stade de France Pharmacy